Vonifimod

N/A

Report date: 2024/07/05 17:47:53

Base Information

Drug NameVonifimod
Drug Alias NameNXC-736
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSphingosine 1-phosphate receptor antagonists
TargetsSphingosine 1-phosphate receptor
Therapy Area/IndicationsAlopecia AreataMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNextgen Biologics Inc
China Registration ClassN/A

Develop Information

Active CompaniesNextgen Biologics IncNextgen Bioscience Inc
Inactive CompaniesN/A
Active IndicationsAlopecia AreataMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A